Patent ID: 7728036
Filing Date: 2010-06-01
Classification: A61K,A61P

Abstract:
1. A method of treating a malignant, premalignant or benign tumor in a subject arising from or associated with a tissue or organ selected from the group consisting of breast, liver, stomach, pancreas, colorectal, colon and prostate, comprising the steps of: (a) providing a composition comprising tetra-O-methyl NDGA and a pharmaceutically acceptable carrier or excipient; and (b) administering the composition to the subject; wherein the composition is administered systemically by a route of administration other than by direct injection into or topical application onto the tumor, wherein the route of administration is selected from the group consisting of oral administration; inhalation administration; intra-arterial administration, with or without occlusion; intracranial administration; intraventricular administration; intravenous administration; intramuscular administration; implantation administration; and central venous administration.